[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceutical Sector in India: Strategic Review (Budget 2012-13)

March 2012 | 9 pages | ID: P934DD8AE2BEN
IS Advisors

US$ 100.00

E-mail Delivery (PDF), Hard Copy Mail Delivery, CD-ROM Mail Delivery, E-mail Delivery (Word)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
India is one of the fastest-growing pharmaceutical markets in the world, and by now its market size has nearly doubled since 2005 and is further expected to reach $20 billion by 2015, growing at a compound annual growth rate (CAGR) of 11.7 percent during 2005-2015 and establish its presence among the world’s leading 10 markets. India is also the third-largest market in the world in terms of volume and fourteenth in terms of value. India’s pharmaceutical sector is gaining a global leadership position and Indian generics today constitute nearly a fifth of global supplies.

IS Advisors takes you through the impact analysis of Union Budget 2012-13 on the Industry in this report. The report provides useful and comprehensive information about the industry expectations from the budget, proposed measures in the budget and their impact on industry and its players.

Scope of the report
  • Industry at a glance
  • List of key Budget expectations
  • Analysis of the various budget provisions affecting the industry
  • Summarize impact on key players of the industry
Reasons to buy

To understand the impact of key government policies on the overall industry and key players
1. OVERVIEW

2. PRE BUDGET EXPECTATIONS

3. KEY BUDGET PROVISIONS

4. BUDGET IMPACT ANALYSIS

4.1 Industry Impact
4.2 Company Impact

LIST OF TABLES & FIGURES

Table 1: Impact on Companies


More Publications